The Battle for Equus: Shareholder Revolt Exposes Deep Governance Cracks

LAKE FOREST, IL – June 24, 2026 – A fifteen-year period of quiet stewardship at Equus Total Return, Inc. (NYSE: EQS) came to an abrupt end this week as activist shareholder Howard Todd Horberg launched a public campaign demanding a radical overhaul of the investment firm. In a sharply worded open letter accompanying a Schedule 13D filing, Horberg, who holds a 5.61% stake, has thrown down the gauntlet ahead of the company's June 30 annual meeting, citing a disastrous track record of value destruction, excessive executive compensation, and a profound lack of board oversight. The move represents the first public challenge to the fund’s management since the current chief executive took the helm in 2011, transforming the upcoming shareholder meeting from a procedural formality into a high-stakes battle for the company's future.

A Record That Warrants Scrutiny

The case presented by Horberg, constructed entirely from Equus's own SEC filings, is a damning portrait of financial decay. The firm’s net asset value (NAV) per share plummeted from $3.55 at the end of 2023 to just $1.19 by year-end 2025. In absolute terms, this translates to an aggregate loss of fund value of approximately $31.6 million, or 65%, in just two years. While the company reported a modest recovery in NAV to $1.50 in the first quarter of 2026, driven by an unrealized gain in a private holding, it does little to mask the longer-term erosion.

Financial performance has been bleak for years. The company recorded a net investment loss of $3.7 million in 2025, its fifth consecutive year in the red. This persistent unprofitability is made more alarming by a heavy operational cost structure. Total operating expenses in 2025 reached $5.1 million—a staggering figure for a company that ended the year with only $133,000 in cash. The situation is so precarious that the company’s independent auditors included a “going-concern” warning in their 2025 report, a red flag indicating substantial doubt about the company’s ability to continue operations. This concern was compounded by the company's failure to repay a $2.0 million senior convertible note that matured in February 2026. Further underscoring the distress, Equus received a non-compliance notice from the New York Stock Exchange in May 2025 after its stock price fell below the $1.00 minimum threshold, narrowly avoiding delisting.

The Governance Disconnect

For critics, the root of the problem lies not just in poor investment returns but in a governance structure that appears to insulate management from the consequences of underperformance. Horberg’s letter shines a spotlight on an executive compensation framework he deems a “defining feature of this governance failure.” In 2025, a year when shareholders saw their NAV per share collapse and received no dividend for the 17th straight year, the three named executive officers collected a combined $1,872,271 in total compensation.

Particularly galling to the activist is the chief executive’s employment contract, which reportedly mandates his base salary escalate annually by the greater of five percent or the Canadian Consumer Price Index—regardless of the fund’s performance. The secretary and chief compliance officer enjoys a similar arrangement tied to the U.S. CPI. “There is, in my opinion, no basis for contractually guaranteed annual raises,” Horberg stated, arguing such terms are indefensible for a company with five straight years of investment losses. This structure, a governance specialist noted, “creates a severe misalignment between the executive experience and the shareholder experience.”

Compounding the issue is a board of directors with little apparent skin in the game. According to Horberg’s analysis of company filings, the three independent directors collectively own less than 0.47% of the company’s outstanding stock. One director, John J. May, owns no shares at all. This lack of meaningful personal investment raises serious questions about the board's alignment with the non-affiliated shareholders they are meant to represent. Meanwhile, directors and executives as a group control over 30% of the stock, with the CEO holding the vast majority of that bloc, creating a powerful insider group at a company where outside shareholders have borne the brunt of the losses.

A Portfolio of Concentration and Concern

Over the years, Equus has ceased to function as a diversified investment vehicle. Today, its portfolio is a highly concentrated bet on two assets. The largest, representing over 63% of net asset value at the end of 2025, is a majority stake in Morgan E&P, a private oil and gas company. The valuation of this illiquid asset is determined entirely by management’s own judgment, a practice Horberg is now challenging. Despite its heavy weighting, Morgan E&P generated only $177,000 in revenue in 2025 while posting a net loss of $7.0 million.

The fund’s only other significant asset is a publicly traded stake in CitroTech, Inc., a fire suppression technology firm. This position, valued at $6.8 million at year-end, represents the company’s primary source of liquidity. In the first quarter of 2026, Equus sold off nearly 100,000 shares of CitroTech, a move likely necessitated by its severe cash crunch. Horberg argues that shareholders are paying $5.1 million a year in overhead for what is essentially “a concentrated holding vehicle for one illiquid private energy asset and one publicly traded fire suppression company.”

A Path Forward or a Proxy War

Horberg is not simply lodging complaints; he is proposing a clear path forward. He calls on the board to immediately suspend the automatic salary escalators and, most critically, to hire an independent financial advisor to explore a strategic review. He believes the company’s structure as a listed investment vehicle is no longer viable and suggests a merger or acquisition by an operating company could unlock value. A core demand is that a third-party appraisal of Morgan E&P must be completed and disclosed before any transaction is considered, bringing transparency to the fund’s main asset.

With the annual meeting just days away, the pressure on the board is immense. They can choose to engage with the activist's proposals, dismiss them and risk a contentious proxy fight, or offer a competing vision for turning the company around. For a company that has operated without public challenge for over a decade, the upcoming shareholder meeting on June 30th has now become a referendum on its very survival and strategic direction.